clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Ultra-Low Energy MRI Shows Its Potential
News & Features
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Informatics
DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released
News & Features
AI Improves Prostate Cancer Recurrence Prediction
News & Features
Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Agilent and Visiopharm Plan to Merge Resources to Market Complimentary Cancer Diagnosis Technology
Pathology
Molecular Dx
Agilent and Visiopharm Plan to Merge Resources to Market Complimentary Cancer Diagnosis Technology
Christina Jackson
-
March 4, 2020
0
News & Features
Testing Panel for Immune Response Following Organ Transplant
Chris Anderson
-
November 11, 2019
0
News & Features
Artificial Intelligence Enhances Oncology
Kathy Vuksanaj
-
October 8, 2019
0
Molecular Dx
AMP Position Statement Offers Laboratories ‘Best Practices’ for PGx Testing
Alex Philippidis
-
September 4, 2019
0
News & Features
Invitae Enhances Variant Interpretation Capabilities with Jungla Acquisition
Chris Anderson
-
July 16, 2019
0
News & Features
PathAI Raises $60M to Further Develop Artificial Intelligence Platform for Pathology
Alex Philippidis
-
April 22, 2019
0
Molecular Dx
Partnership Joins MolecularMD Dx Services, Indica Labs Imaging Expertise
Inside Precision Medicine Staff Writer
-
October 2, 2017
0
News & Features
Mount Sinai Unveils the Center for Computational and Systems Pathology
Inside Precision Medicine Staff Writer
-
August 23, 2016
0
News & Features
LabCorp Buys Pathology
Inside Precision Medicine Staff Writer
-
December 10, 2015
0
1
2
3
4
Page 4 of 4
Related Content
Ultra-Low Energy MRI Shows Its Potential
DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released
AI Improves Prostate Cancer Recurrence Prediction
Novel AI Platform Designs Cancer Drugs to Hit Multiple Targets
Inside Precision Medicine
![MolecularMD’s diagnostic clinical testing solutions will be combined with Indica Labs’ digital pathology imaging tools and services under a partnership announced by the companies. [Source: everythingpossible/iStock]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1276.jpeg "Partnership Joins MolecularMD Dx Services, Indica Labs Imaging Expertise")
